Wenping Lin
Overview
Explore the profile of Wenping Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
414
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin W, Cai Z, Liang J, Miao P, Ruan Y, Li P, et al.
Drug Dev Res
. 2024 Dec;
85(8):e70033.
PMID: 39660541
Microglia-mediated neuroinflammatory responses have a critical function in the spinal cord injury (SCI) mechanism, and targeted modulation of microglia activity has emerged as a new therapeutic strategy for SCI. Heme...
2.
Yu Q, Cai Z, Liu X, Lin S, Li P, Ruan Y, et al.
J Integr Neurosci
. 2024 Sep;
23(9):171.
PMID: 39344231
Spinal cord injury (SCI) is a severe central nervous system disorder with no currently available effective treatment. Microglia are immune cells in the central nervous system that play crucial roles...
3.
Ruan Y, Cai Z, Kang Z, Liang J, Tian H, Yu Q, et al.
J Biochem Mol Toxicol
. 2024 Aug;
38(8):e23808.
PMID: 39132830
Oxidative stress is a hallmark of secondary injury of spinal cord injuries. Controlling oxidative stress is crucial for mitigating secondary injury and promoting functional recovery after spinal cord injuries. Calycosin...
4.
Wen Y, Lu L, Mei J, Ling Y, Guan R, Lin W, et al.
J Hepatocell Carcinoma
. 2024 Apr;
11:665-678.
PMID: 38596593
Background: Microvascular invasion (MVI) is a significant pathological feature in hepatocellular carcinoma (HCC), adjuvant hepatic arterial infusion chemotherapy (a-HAIC) and adjuvant transcatheter arterial chemoembolization (a-TACE), are commonly used for HCC...
5.
Lin W, Lu L, Zheng R, Yuan S, Li S, Ling Y, et al.
J Cancer Res Clin Oncol
. 2023 Oct;
149(19):17231-17239.
PMID: 37801135
Purpose: Vessels encapsulating tumor clusters (VETC) is a novel vascular pattern structurally and functionally distinct from microvascular invasion (MVI) in hepatocellular carcinoma (HCC). This study aims to explore the prognostic...
6.
Chen W, Li Z, Yu N, Zhang L, Li H, Chen Y, et al.
J Nanobiotechnology
. 2023 Sep;
21(1):355.
PMID: 37775799
Background: In recent years, the development of BMSCs-derived exosomes (EXO) for the treatment of osteosarcoma (OS) is a safe and promising modality for OS treatment, which can effectively deliver drugs...
7.
Deng M, Zhao R, Guan R, Li S, Zuo Z, Lin W, et al.
Eur J Med Res
. 2023 Sep;
28(1):328.
PMID: 37689775
Background: Lack of opportunity for radical surgery and postoperative tumor recurrence are challenges for surgeons and hepatocellular carcinoma (HCC) patients. This study aimed to develop nomograms to predict recurrence risk...
8.
Guan R, Mei J, Lin W, Deng M, Li S, Guo R
Hepatol Int
. 2023 May;
17(5):1279-1288.
PMID: 37129721
Background: The level of C‑reactive protein (CRP) and alpha‑fetoprotein (AFP) in immunotherapy (CRAFITY) score was associated with the prognosis of hepatocellular carcinoma (HCC) patients treated with immunotherapy. Based on the...
9.
Guan R, Mei J, Li S, Lin W, Deng M, Wei W, et al.
Hepatol Int
. 2023 Jan;
17(3):765-769.
PMID: 36609671
No abstract available.
10.
Chen W, Lin W, Yu N, Zhang L, Wu Z, Chen Y, et al.
Int J Nanomedicine
. 2022 Nov;
17:5431-5446.
PMID: 36426375
Purpose: To investigate induction of cell death in Osteosarcoma (OS) using the anti-tuberculosis drug, rifampicin, loaded into exosomes. Patients And Methods: BMSC-exosomes were isolated by ultracentrifugation and loaded ultrasonically with...